FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to (R)-4-(heteroaryl)phenyl compounds of formula ,
where X represents heteroatom, selected from -S or O, Y represents H or residue, selected from group, consisting of - linear or branched C1-C4-alkyl, halogen-C1-C3-alkyl; Z represents heteroaryl ring, selected from group, consisting of unsubstituted tetrazole and triazole, pyrazole, thiazole, isoxazole, isothiazole, thiadiazole and oxadiazole, substituted with one hydroxyl group and optionally additionally substituted with linear C1-C4-alkyl. (R)-4-(heteroaryl)phenylethyl derivatives of formula (I), which can be used for application in treatment of diseases, into which C5a-induced human PMN-chemotaxis is involved. Formula (I) compounds, where Z represents tertazole, is obtained by interaction of formula
compound with trimethylsililazide.
EFFECT: obtaining (R)-4-(heteroaryl)phenylethyl derivatives, possessing high selectivity and activity in inhibition of C5a-induced chemotaxis of neutrophils.
7 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
(R)-ARYLALKYLAMINO DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2006 |
|
RU2458051C2 |
2-ARYLPROPIONIC ACIDS AND DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS, CONTAINING THEREOF | 2009 |
|
RU2520212C2 |
(2R)-2-[(4-SULPHONYL)AMINOPHENYL]PROPANAMIDE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2007 |
|
RU2457201C2 |
NEW DERIVATIVES OF 5, 7-DISUBSTITUTED [1, 3] THIAZOLO[4, 5-D] PYRIMIDINE-2(3H)-ONE | 2006 |
|
RU2411245C9 |
TYPE 1 DIACYLGLYCEROL-O-ACYLTRANSFERASE ENZYME INHIBITORS | 2008 |
|
RU2486186C2 |
HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR USE | 2012 |
|
RU2648997C2 |
CONDENSED 4-OXOPYRIMIDINE DERIVATIVE | 2005 |
|
RU2358969C2 |
PRODRUGS OF CONJUGATED BICYCLIC C5aR ANTAGONISTS | 2019 |
|
RU2794327C2 |
INDOLE AND INDAZOLE DERIVATIVES SHOWING PRESERVING ACTION ON CELLS, TISSUES AND ORGANS | 2009 |
|
RU2460525C2 |
N-PHENYLARYLSULFONYLAMIDE, PHARMACEUTICAL COMPOSITION CONTAINING INDICATED SUBSTANCE AS ACTIVE COMPONENT, COMPOUND AS INTERMEDIATE IN SYNTHESIS OF INDICATED COMPOUND AND METHOD FOR ITS PREPARING | 2002 |
|
RU2299202C2 |
Authors
Dates
2013-02-20—Published
2008-10-17—Filed